Immunotherapy prior to colon cancer surgery is exceptionally effective


Patients with a particular colon cancer subtype appear to respond exceptionally well to short-term immunotherapy treatment while awaiting their surgery. A new study shows that this treatment is highly successful in almost all patients; in two-thirds, the cancer cells had even disappeared entirely before surgery. Researchers from the Netherlands Cancer Institute have presented these results at the ESMO congress in Paris on September 11.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.